
Vland Biotech released its semi-annual performance report, with a net profit attributable to the parent company of 26.72 million yuan, a year-on-year decrease of 8.98%

I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Vland Biotech disclosed its semi-annual report for 2025, reporting revenue of 652 million yuan, a year-on-year increase of 7.05%; net profit attributable to the parent company of 26.72 million yuan, a year-on-year decrease of 8.98%; net profit excluding non-recurring items of 16 million yuan, a year-on-year increase of 4.17%; and basic earnings per share of 0.11 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

